Published in Vaccine Weekly, February 19th, 2003
"In a previous clinical trial comparing COMVAX with its monovalent components, PedvaxHIB and RECOMBIVAX HB, 1 of 92 comparisons of postvaccination adverse experiences revealed a higher rate of unusual, high-pitched crying following the second but not the first or third...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.